136 related articles for article (PubMed ID: 25247654)
1. Advances in molecular markers of germ cell cancer in patients with disorders of sex development.
van der Zwan YG; Cools M; Looijenga LH
Endocr Dev; 2014; 27():172-84. PubMed ID: 25247654
[TBL] [Abstract][Full Text] [Related]
2. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model.
van der Zwan YG; Biermann K; Wolffenbuttel KP; Cools M; Looijenga LH
Eur Urol; 2015 Apr; 67(4):692-701. PubMed ID: 25240975
[TBL] [Abstract][Full Text] [Related]
3. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers.
Cools M; Drop SL; Wolffenbuttel KP; Oosterhuis JW; Looijenga LH
Endocr Rev; 2006 Aug; 27(5):468-84. PubMed ID: 16735607
[TBL] [Abstract][Full Text] [Related]
4. Gonadal development and tumor formation at the crossroads of male and female sex determination.
Cools M; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Looijenga LH
Sex Dev; 2011; 5(4):167-80. PubMed ID: 21791949
[TBL] [Abstract][Full Text] [Related]
5. Managing the risk of germ cell tumourigenesis in disorders of sex development patients.
Cools M; Looijenga LH; Wolffenbuttel KP; T'Sjoen G
Endocr Dev; 2014; 27():185-96. PubMed ID: 25247655
[TBL] [Abstract][Full Text] [Related]
6. The biology of germ cell tumors in disorders of sex development.
Hersmus R; van Bever Y; Wolffenbuttel KP; Biermann K; Cools M; Looijenga LH
Clin Genet; 2017 Feb; 91(2):292-301. PubMed ID: 27716895
[TBL] [Abstract][Full Text] [Related]
7. Tumor risk and clinical follow-up in patients with disorders of sex development.
Cools M; Looijenga LH
Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():519-24. PubMed ID: 22423509
[TBL] [Abstract][Full Text] [Related]
8. A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development.
Pyle LC; Nathanson KL
Am J Med Genet C Semin Med Genet; 2017 Jun; 175(2):304-314. PubMed ID: 28544305
[TBL] [Abstract][Full Text] [Related]
9. Tumor risk in disorders of sex development.
Pleskacova J; Hersmus R; Oosterhuis JW; Setyawati BA; Faradz SM; Cools M; Wolffenbuttel KP; Lebl J; Drop SL; Looijenga LH
Sex Dev; 2010 Sep; 4(4-5):259-69. PubMed ID: 20558977
[TBL] [Abstract][Full Text] [Related]
10. Gonadal tumours and DSD.
Looijenga LH; Hersmus R; de Leeuw BH; Stoop H; Cools M; Oosterhuis JW; Drop SL; Wolffenbuttel KP
Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):291-310. PubMed ID: 20541153
[TBL] [Abstract][Full Text] [Related]
11. Germ cell cancer risk in DSD patients.
Cools M
Ann Endocrinol (Paris); 2014 May; 75(2):67-71. PubMed ID: 24786700
[TBL] [Abstract][Full Text] [Related]
12. Germ cell tumor showing partial trisomy 1 in a gonadectomized intersex child with monosomy X and double Y mosaicism.
Ogur G; Pinarli FG; Dağdemir A; Artan S; Artürk E; Elli M; Sezer OT; Okten G
J Pediatr Hematol Oncol; 2006 Nov; 28(11):750-4. PubMed ID: 17114963
[TBL] [Abstract][Full Text] [Related]
13. Tumor risk in disorders of sex development (DSD).
Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP
Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic analysis of bilateral ovarian germ cell tumors.
Hennes E; Zahn S; Lopes LF; Schönberger S; Leuschner I; Göbel U; Calaminus G; Schneider DT
Klin Padiatr; 2012 Oct; 224(6):359-65. PubMed ID: 23143763
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance.
Looijenga LH; Gillis AJ; Stoop H; Biermann K; Oosterhuis JW
Int J Androl; 2011 Aug; 34(4 Pt 2):e234-51. PubMed ID: 21564133
[TBL] [Abstract][Full Text] [Related]
16. Role of epigenetics in the etiology of germ cell cancer.
Van Der Zwan YG; Stoop H; Rossello F; White SJ; Looijenga LH
Int J Dev Biol; 2013; 57(2-4):299-308. PubMed ID: 23784841
[TBL] [Abstract][Full Text] [Related]
17. The use of tumor markers in germ cell malignancies.
Bosl GJ; Chaganti RS
Hematol Oncol Clin North Am; 1994 Jun; 8(3):573-87. PubMed ID: 8707773
[TBL] [Abstract][Full Text] [Related]
18. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD).
Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH
Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the pathology and classification of gonadal neoplasms composed of germ cells and sex cord derivatives.
Talerman A; Roth LM
Int J Gynecol Pathol; 2007 Jul; 26(3):313-21. PubMed ID: 17581418
[TBL] [Abstract][Full Text] [Related]
20. Gonadal malignancy in 13 consecutive collected patients with disorders of sex development (DSD) from Semarang (Indonesia).
Juniarto AZ; Setyawati BA; Miranti IP; Santosa A; Hersmus R; Stoop H; Cools M; Oosterhuis JW; Drop SL; Faradz SM; Looijenga LH
J Clin Pathol; 2013 Mar; 66(3):198-204. PubMed ID: 23268320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
